Global Peptide Synthesis Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
“Global Peptide Synthesis Market” is an upcoming report by MarketResearch.biz. The global peptide synthesis market segmentation allows for deeper understanding and thought, to decisively assess, analyze, and study. Besides revenues for segments, global, regional, and country-wise, market revenue segmentation will be compiled in a fastidious manner for clear flow and understanding. The analysis will be conducted using expert opinions and inputs, as well as comprehensive primary and secondary research efforts to establish various aspects of the peptide synthesis market. The global peptide synthesis market report will be segmented on the basis of product, technology, application, end-use, and region.
In organic chemistry, peptide synthesis is the manufacture of peptides, compounds where amino acids are linked via amide bonds, also known as peptide bonds. They are clinically synthesized by the condensation reaction of the carboxyl group of one amino acid to the amino group of another.
Peptide molecules have gained substantial momentum in both the nutrition and healthcare industries respectively. Several advancements in technology have implemented to perform a required peptide synthesis.
Chemical peptide synthesis is considered to a widely used yet conventional method of peptide production. Regardless, the risk of increasing the environmental burden as a result of its production is forecasted to hamper the growth of the global peptide synthesis market. This has led to advancements in the implementation of enzymatic peptide synthesis. The disadvantages associated with this technology are as follows – expensive biocatalysts, a lack of validation protocols, and lesser productivity. These challenges hinder the production of peptides using enzymatic methods. Vast amounts of research and heightened focus has been placed on developing an effective peptide synthesis technology. And, this has caused a conjunctional approach in applying the benefits of both chemical and enzymatic synthesis technologies synergically.
In terms of product, the market is segmented into reagents, equipment, and others. The peptide synthesis equipment segment is further categorized into – lyophilizers, protein synthesizers, and chromatography equipment among others. A primary factor that has led to the exponential growth of this segment id the extensive research efforts to developing peptide synthesis equipment. However, the reagents & consumables segment will account for the highest revenue growth due to its adoption of peptide synthesis protocols over the forecast period.
With regard to technology, the market is sectioned into – liquid phase peptide synthesis (LPPS), solid-phase peptide synthesis (SPPS) and hybrid technology. The liquid phase peptide synthesis technology accounted for a majority of the revenue share in 2018 and the solid phase peptide synthesis technology is anticipated to index the fastest growth over the coming years.
Regarding application, the market is categorized into – diagnosis, therapeutics, and research. The therapeutics segment accounted for a majority of the market’s revenue share in 2018 and is slated to continue to do so over the next ten years. However, the metabolic disorders segment is projected to index the quickest growth over the coming years owing to a vast number of peptide candidates meant for type II diabetes treatment.
Based on end-use, the market is segregated into contract development & manufacturing organizations (CMO)/contract research organizations (CRO), academic & research institutes, and pharmaceutical & biotechnological companies. The pharmaceutical & biotechnological companies segment accounted for a majority revenue share of the market and the CMO & CRO segments are expected to index the quickest rate of growth over the next ten years.
The market in North America accounted for the highest revenue share in 2018 due to an increase in awareness of peptide synthesis technologies, focus on commercial-scale distribution and the presence of major market players.
The Asia Pacific market is projected to index the quickest growth rate over the next ten years due to the rising incidence of chronic diseases, collaborations between local players and corporations for distribution, increasing investments by key market players, increased government healthcare spending, etc.
Global Market Segmentation:
Global market segmentation, by Technology:
- Solid Phase Peptide Synthesis (SPPS)
- Liquid Phase Peptide Synthesis (LPPS)
- Hybrid Technology
Global market segmentation, by Product:
- Peptide Synthesizers
- Chromatography Equipment
- Reagents & Consumables
Global market segmentation, by Application:
- Cardiovascular Disorder
- GIT (Gastrointestinal Disorders)
- Infectious Diseases
Global market segmentation, by End-use:
- Pharmaceutical & Biotechnology Companies
- Contract Development & Manufacturing Organization/Contract Research Organization
- Academic & Research Institutes
Global market segmentation, by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- Genscript Biotech
- Merck KGaA
- Bachem Holdings
- CEM Corporation
- Thermo Fisher
- Creative Diagnostics
- Polypeptide Group
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!